FDA Approves Pregabalin Application ANDA219593 by Unichem
The FDA has approved the ANDA219593 application for Pregabalin submitted by Unichem.
Asset / Drug
Drug and asset intelligence for Unichem with 7 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
The FDA has approved the Abbreviated New Drug Application (ANDA) for Pregabalin submitted by Unichem.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.